简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2025-03-03 10:21 Astria Therapeutics Initiates ALPHA-ORBIT Phase 3 Pivotal Trial of Navenibart in Hereditary Angioedema
2025-03-03 10:12 SINOVAC Announces New Board Pursuant to Privy Council Judgment and Order
2025-02-28 17:55 Cynosure Lutronic and Amico Aesthetics Join Forces by Signing a Strategic Distribution Agreement for the Middle East
2025-02-28 09:27 The Estée Lauder Companies Partners with Serpin Pharma, Inc to Develop Breakthrough Skin Care Ingredients to Advance Longevity
2025-02-25 14:50 Bureau Veritas' LEAP | 28 Strategy Delivers Outstanding Results in 2024; Confident 2025 Outlook
2025-02-24 10:59 Erectile Dysfunction: The PelviTouch Revolution Comes From DEKA’s Italian Technology
2025-02-21 12:47 CareDx Announces Study Showing AlloSeq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients
2025-02-21 12:38 Triastek D23 (Budesonide Ileum Targeted Tablets) Receives Positive Clinical Results
2025-02-21 11:13 Ferrer is the Highest-performing Pharmaceutical Company in the World for Social and Environmental Impact According to B Corp
2025-02-21 10:35 Celltrion Unveils New Post-Hoc Analyses of LIBERTY Studies at the 20th ECCO Congress Further Evaluating the Efficacy and Safety of Subcutaneous (SC) Infliximab
2025-02-20 14:46 Parse Biosciences Launches 5 Million Cell Evercode WT Penta Kit for Single Cell Sequencing
2025-02-20 14:13 Celltrion Expands Biosimilar Portfolio in the European Union Following European Commission Approval of Two Biosimilars
2025-02-19 10:55 Italian Tennis Star Jasmine Paolini Joins Amazfit as Latest Athlete Ambassador
2025-02-19 10:08 Novotech Partners with Wonju Severance Christian Hospital to Drive Clinical Research Excellence in Korea
2025-02-18 16:05 Galderma’s Nemluvio® (Nemolizumab) Granted Marketing Authorization in the United Kingdom and Switzerland for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis
2025-02-18 10:39 ICC Arbitral Tribunal Rules in Favor of AOP Health in Arbitration Proceedings Pertaining to BESREMi® (Ropeginterferon alfa-2b)
2025-02-14 17:34 Galderma’s Nemluvio® (Nemolizumab) Approved in the European Union for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis
2025-02-13 14:58 SBC Medical Group Holdings Announces its Purchase of Bitcoin
2025-02-11 14:38 Zayed Sustainability Prize Opens Global Call for Transformative Solutions
2025-02-11 14:22 PHC and CCRM Collaborate to Develop Primary T-Cell Expansion Culture Processes to Enhance Efficiency and Improve Cell Quality

Business Wire Weibo

Press Releases

Latest Releases